PMS Review

Listen to this article Quick Summary What Works What Doesn’t Fund manager has run the strategy since almost inception (joined ASK Jan 2018, portfolio launched Jun 2018) — low key-person risk Trailed the average actively managed flexi-cap mutual fund on a net-of-fee basis across the 1-year, 3-year, 5-year and since-inception trailing windows Concentrated, high-conviction ~25-stock […]

Listen to this article Quick Summary What Works What Doesn’t Consistent positive alpha over every disclosed period — 1-year (+11.34%), 2-year (+3.25%), 3-year (+4.95%) and since inception (+4.53%) — against its passive benchmark Stock count, average market cap and sector weights aren’t publicly published for this strategy — standard practice for many PMS providers, but […]

Listen to this article Quick Summary What Works What Doesn’t Genuinely strong transparency: top 10 holdings and key sector positioning disclosed with overweight/underweight detail versus both BSE 500 and Nifty 50 Negative alpha versus both benchmarks across 1-year, 2-year, 3-year, 5-year, and 10-year periods — not a one-off soft patch Reasonably diversified at the top […]

Listen to this article Quick Summary What Works What Doesn’t One of the longer track records in the PMS space — over 8 years since a January 2018 inception Underperformed its benchmark over the most recent 1-year period, and by a meaningful margin Founder-led by Pankaj Murarka, with a genuinely strong prior track record at […]

Listen to this article Quick Summary What Works What Doesn’t Positive alpha since inception against three of the four key benchmarks tested Over the last year, alpha trails the average actively managed mutual fund in the same category — across every single benchmark measured Ten-year track record (inception July 2016), 65.55% positive months since inception […]

Listen to this article Quick Summary What Works What Doesn’t Positive net alpha over the 5-year (+0.48%), 10-year (+1.38%) and since-inception (+11.04%) periods Negative net return, and negative alpha, over the trailing 1-year (-2.90%, alpha -0.94%) and 2-year (-1.57%, alpha -3.09%) periods Long, disciplined 13.5-year track record run by the same MD & CIO 3-year […]